Skip to content

Evaluation of Quality of Life in Patients After Placement of a Modified Double J Ureteral Stent

Evaluation of Quality of Life in Patients After Placement of a Modified Double J Ureteral Stent. Randomized Clinical Trial.

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07275879
Enrollment
40
Registered
2025-12-10
Start date
2025-12-28
Completion date
2026-04-30
Last updated
2025-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Quality of Life, Ureteral Double-J Stent, Urolithiasis

Brief summary

Double-J (DJ) stents are commonly inserted after ureteroscopy. There are several complications associated with the presence of DJ stent: urinary tract infection, stent encrustation, stent migration, and stent-related symptoms (SRS). SRS occur in up to 80% of patients and include pain, hematuria, and dysuria, all of which negatively impact the patient's quality of life. Physicians proposed the distal end of the ureteral stents might involve in SRS by over-simulating the trigone of bladder. The design of the distal end, made with a thinner loop than that of a standard DJ stent, is intended to mitigate SRS and reduce urine reflux.

Detailed description

Study Design: Prospective, randomized, open-label, controlled trial with two parallel arms. Study Center: Department of Urology, St. Luke's Clinical Hospital, St. Petersburg, Russia Study Population: All patients should not be prestented and should have no ureteral obstruction. 40 patients, divided into four equal groups of 20 people each: Group I (standard DJ stent): Group II (modified DJ stent) Procedure for evaluation: After surgery ( RIRS, ureteroscopy) reflux is assessed (gravity-filling cystogram). After stenting, the presence of post-stent reflux is assessed. In the postoperative period, patients complete the USSQ (1st day, 7th day and before stent removal). Statistics method: The results are presented as the median and interquartile range (IQR) for continuous variables, and as frequencies (n with percentage %) for categorical variables. Statistical comparisons of all primary and secondary outcome measures between different treatment groups were conducted using the Mann-Whitney U test for continuous data. Meanwhile, categorical variables were analyzed using either Pearson's chi-square (χ²) test or Fisher's exact test, where appropriate. Thenthreshold for statistical significance was established at 5%, implying that a p-value less than 0.05 (p \< 0.05) was considered statistically significant for all tests performed.

Interventions

PROCEDUREUreteric stent insertion

Ureteric stent insertion is the procedure to place a thin, flexible plastic tube that is temporarily in the ureter to help urine drain. They are placed with cystoscopic and X-ray guidances in an operating room setting

Sponsors

St. Luke's Clinical Hospital, Russia
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients aged 18 years and older * Patients with kidney stones * Patients with ureteral stones

Exclusion criteria

* Congenital anomalies of the urinary tract * Urinary tract infections * Upper urinary tract obstruction * Complicated ureteroscopy (e.g., ureteral perforation) * Pregnancy * Pre-stented patients

Design outcomes

Primary

MeasureTime frameDescription
ureteral refluxIntraoperativeInjection of raradiopaque dye using gravity- filling cystogram followed by X-ray imaging. If contrast entered or not entered the ureter and kidney, ureteral reflux was considered positive or not, respectively.
Assessment the Ureteral Stent Symptom Questionnaire (USSQ)Postoperative: 1st and 7th day, before stent removalUreteral stent symptom questionnaire (USSQ) a psychometrically valid measure to evaluate symptoms and impact on quality of life of ureteral stents. USSQ contains 38 questions and 2 visual analog scales (VAS), allowing assessment of the severity of SRS and their impact on the patient's quality of life. The questions are grouped into 6 domains: Urinary symptoms Pain General health Work performance Sexual matters Additional problems For each domain, a score index is calculated as the sum of the points from all questions in that domain. The scale scores range from 1 to 10, with higher values indicating more severe SRS and lower quality of life.

Secondary

MeasureTime frameDescription
Body mass index (BMI)PreoperativeBody mass index (BMI) is a value derived from the mass (weight) and height of a person. BMI = kg/m2
Patient's heightPreoperativeThe patient's height is measured in centimeters.
SurgeryPreoperativeType of surgery: ureteroscopy or retrograde intrarenal surgery or stenting
Operative timeIntraoperative (measured from start to end of procedure)total operative time in minutes
Patient's weightPreoperativeThe patient's weight is measured in centimeters.

Countries

Russia

Contacts

Primary ContactDmitriy Sytnik
doc.dmitriysytnik@gmail.com+7 931 367 78 58
Backup ContactYury Mikheev
mikheevyra@gmail.com+79315412190

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026